Accumulating evidence suggests anti-TNF therapy needs to be given trial priority in COVID-19 treatment

Bibliografske podrobnosti
Main Authors: Robinson, PC, Richards, D, Tanner, HL, Feldmann, M
Format: Journal article
Jezik:English
Izdano: Elsevier 2020